-
Reducing sialylation in melanoma increases classical pathway-mediated complement activation
Coccimiglio, M., Clayton, G., Toffoli, E. C., de Gruijl, T. D., Pouw, R. B., Chiodo, F. & van Kooyk, Y., 18 Sept 2026, In: iScience. 29, 9, 117326.Research output: Contribution to Journal › Article › Academic › peer-review
-
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanoma
Notohardjo, J. C. L., Toffoli, E. C., Muijlwijk, T., van den Hout, M. F. C. M., Kandiah, V., Labots, M., van de Ven, R., van den Eertwegh, A. J. M. & de Gruijl, T. D., 1 Jan 2026, In: OncoImmunology. 15, 1, 2662708.Research output: Contribution to Journal › Article › Academic › peer-review
-
Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulation
Clayton, G., Toffoli, E. C., de Gruijl, T. D. & van Kooyk, Y., 18 Nov 2025, In: Cell Rep. Med.. 6, 11, p. 102412 1 p.Research output: Contribution to Journal › Review article › Academic › peer-review
- All publications
